Skip to main content
SpringerLink
Log in

Ist die Radiojodtherapie nach Thyreoidektomie beim „niedrig-Risiko“-differenzierten Schilddrüsenkarzinom erforderlich?

Ergebnisse der französischen prospektiv randomisierten Multicenterstudie ESTIMABL2

Is radioiodine treatment necessary after thyroidectomy for “low-risk” differentiated thyroid cancer?

Results of the French prospective randomized multicenter ESTIMBL2 study

  • Journal Club
  • Published:
Die Chirurgie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Klinik für Visceral‑, Thorax- und Gefäßchirurgie, Philipps-Universität Marburg, Baldingerstr., 35043, Marburg, Deutschland

    Detlef K. Bartsch &  Elisabeth Maurer

Authors
  1. Detlef K. Bartsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabeth Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisabeth Maurer.

Ethics declarations

Interessenkonflikt

D.K. Bartsch und E. Maurer haben keinen Interessenskonflikt.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bartsch, D.K., Maurer, E. Ist die Radiojodtherapie nach Thyreoidektomie beim „niedrig-Risiko“-differenzierten Schilddrüsenkarzinom erforderlich?. Chirurgie 94, 168–169 (2023). https://doi.org/10.1007/s00104-022-01797-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-022-01797-3

Search

Navigation